Researchers at the University of Cambridge have found a new way to repair myelin using a well-established treatment for breast cancer.
Tamoxifen has been used to treat breast cancer since the early 1970s, but research has revealed some previously unknown benefits of the treatment.
Dr Mark Kotter, who led the project, said: «We’re very excited about our findings. We looked at six existing drugs for a range of conditions as part of our work. What we discovered was that Tamoxifen can enhance myelin repair in MS by encouraging the brain’s…
da : www.mssociety.org.uk